| Literature DB >> 27430340 |
Lifang Chen1, Jianqiao Fang2,3, Ruijie Ma1, Xudong Gu4, Lina Chen5, Jianhua Li6, Shouyu Xu7.
Abstract
BACKGROUND: Acupuncture is not considered a conventional therapy for post-stroke sequelae but it might have some additional positive effects on early rehabilitation. We conducted this trial to determine whether acupuncture has additional effects in early comprehensive rehabilitation for acute ischemic stroke and dysfunctions secondary to stroke.Entities:
Keywords: Acupuncture; Randomized controlled trial; Rehabilitation; Stroke
Mesh:
Year: 2016 PMID: 27430340 PMCID: PMC4950630 DOI: 10.1186/s12906-016-1193-y
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Baseline characteristics of trial participants
| Variable | AG | NAG |
|
|---|---|---|---|
| Age, Mean (SD), y | 62.52(10.60) | 64.06(10.54) | 0.231 |
| Male sex, n (%) | 74(59.20) | 74(59.20) | 1.000 |
| Left side of hemiparesis, n (%) | 83(66.40) | 79(63.20) | 0.596 |
| OCSP infarct classification, n (%) | 0.847 | ||
| TACI | 22(17.60) | 19(15.20) | |
| PACI | 70(56.00) | 71(56.80) | |
| LACI | 25(20.00) | 29(23.20) | |
| Unknown/Other | 8(6.40) | 6(4.80) | |
| NIHSS, Mean (SD) | 8.31(2.43) | 7.75(2.72) | 0.054 |
| FMA, Mean (SD) | 46.06(14.96) | 49.28(15.90) | 0.175 |
| BSA positive, n (%)a | 103(82.40) | 97(77.60) | 0.343 |
| VFSS Assessment, n (%)b | 68(66.02) | 65(67.01) | 0.881 |
| VFSS, Mean (SD)b | 5.26(1.57) | 5.55(1.76) | 0.319 |
| Cognitive impairment, n (%)a | 78(62.40) | 71(56.80) | 0.367 |
| Education level, (years)c | 0.397 | ||
| 0–5, n (%) | 20(25.64 %) | 21(29.58 %) | |
| 5–8, n (%) | 29(37.18 %) | 31(43.66 %) | |
| >8, n (%) | 29(37.18 %) | 19(26.76 %) | |
| Age, mean (SD), yc | 63.85(10.61) | 64.06(10.39) | 0.903 |
| MoCA, Mean (SD) | 18.27(2.01) | 18.35(2.11) | 0.806 |
| MMSE, Mean (SD) | 20.86(2.64) | 20.97(2.65) | 0.795 |
Abbreviations: AG Acupuncture group, NAG No acupuncture group, OCSP Oxfordshire Community Stroke Project, TACI Total anterior circulation infarcts, PACI Partial anterior circulation infarcts, LACI Lacunar infarcts, NIHSS National Institutes of Health Stroke Scale, FMA Fugl-Meyer Assessment, BSA Bedside Swallowing Assessment, VFSS Video-fluoroscopic Swallowing Study, MoCA Montreal Cognitive Assessment, MMSE Mini-mental State Examination
aFAS analysis included 250 cases. The analysis of swallowing disorder was made on the cases who tested positive for the BSA, the analysis of cognitive impairment was made on the cases who tested MMSE ≤ 24 and MoCA ≤ 20
bOf 200 swallow disorders, 133 patients received VFSS assessment voluntarily, others could not participate due to physical limitations or refused to accept the test
cPatients with cognitive impairment should be first compared with education level and age. 0–5 years education level means elementary school, 5–8 years education level means middle school, >8 years education level means above high middle school
Fig. 1Flow of participants through the trial
Variables at each testing time point, Mean (SD)
| Variables | Group (N) | Week 0 | Week 1 | Week 3 | Week 7 |
|---|---|---|---|---|---|
| NIHSS | AG (120) | 8.33(2.43) | 6.61(2.47) | 4.95(2.44) | 3.48(2.26) |
| NAG (121) | 7.71(2.71) | 6.20(2.69) | 4.43(2.53) | 3.66(2.25) | |
| FMA | AG (120) | 46.12(14.96) | – | 54.21(14.70) | 64.41(14.17) |
| NAG (121) | 50.25(15.90) | – | 57.87(16.84) | 66.85(16.51) | |
| VFSS | AG (68) | 5.26(1.57) | – | – | 9.77(0.45) |
| NAG (65) | 5.55(1.76) | – | – | 9.35(0.77) | |
| MMSE | AG (78) | 20.86(2.64) | – | 22.51(2.67) | 23.80(2.16) |
| NAG (71) | 20.97(2.64) | – | 22.08(2.74) | 23.12(2.95) | |
| MoCA | AG (78) | 18.27(2.01) | – | 20.02(2.34) | 21.51(2.26) |
| NAG (71) | 18.35(2.11) | – | 19.56(2.36) | 20.78(2.45) |
No differences were found between two groups at each testing time point. NIHSS was estimated at week 0 (baseline), week 1 (during the intervention), week 3 (after treatment), and week 7 (follow-up); FMA, MMSE, and MoCA were assessed at week 0, week 3, and week 7; VFSS was evaluated at week 0 and week 7
Results of repeated measures ANOVA for outcomes (PPS)
| Variables |
|
| Effects | F |
| Significance |
|---|---|---|---|---|---|---|
| Effect | Error | |||||
| NIHSS | 1 | 239 | Group | 1.72 | 0.192 | NS |
| 3 | 237 | Time | 675.34 | <0.001 | S | |
| 3 | 237 | Group by time | 10.69 | <0.001 | S | |
| FMA | 1 | 239 | Group | 2.83 | 0.094 | NS |
| 2 | 238 | Time | 775.87 | <0.001 | S | |
| 2 | 238 | Group by time | 2.04 | 0.133 | NS | |
| VFSS | 1 | 131 | Group | 0.502 | 0.480 | NS |
| 1 | 131 | Time | 1500.16 | <0.001 | S | |
| 1 | 131 | Group by time | 11.50 | 0.001 | S | |
| MMSE | 1 | 147 | Group | 0.62 | 0.433 | NS |
| 2 | 146 | Time | 316.24 | <0.001 | S | |
| 2 | 146 | Group by time | 8.74 | <0.001 | S | |
| MoCA | 1 | 147 | Group | 1.06 | 0.305 | NS |
| 2 | 146 | Time | 350.57 | <0.001 | S | |
| 2 | 146 | Group by time | 8.00 | 0.001 | S |
df indicates degrees of freedom. NS, not significant; S, significant
Value changes (week 7-week 0) of variables by independent samples t-test (PPS)
| Variable | Group (N) | week 7-week 0 | 95 % CI of the Difference |
|
|
|---|---|---|---|---|---|
| NIHSS | AG(120) | −4.85(1.63) | −1.22, −0.43 | −4.13 | <0.001 |
| NAG(121) | −4.05(1.52) | ||||
| FMA | AG(120) | 18.29(7.32) | −0.77, 2.85 | 1.13 | 0.259 |
| NAG(121) | 16.60(10.41) | ||||
| FMA (UE) | AG(120) | 7.26(3.40) | −0.68, 1.00 | 0.14 | 0.707 |
| NAG(121) | 7.10(3.22) | ||||
| FMA (LE) | AG(120) | 11.83(3.72) | 0.18, 2.01 | 5.52 | 0.020 |
| NAG(121) | 10.73(3.54) | ||||
| VFSS | AG(68) | 4.51(1.39) | 0.27,1.16 | 3.17 | 0.002 |
| NAG(65) | 3.80(1.20) | ||||
| MMSE | AG(78) | 2.95(1.26) | 0.39, 1.20 | 3.90 | <0.001 |
| NAG(71) | 2.15(1.23) | ||||
| MoCA | AG(78) | 3.24(1.40) | 0.38, 1.23 | 3.77 | <0.001 |
| NAG(71) | 2.44(1.19) |
FMA (UE) = FMA subscale of upper extremity (66 points); FMA (LE) = FMA subscale of lower extremity (34 points)
Recovery rate of swallow function between two groups
| Time | Group (N) | N (%) |
|
|
|---|---|---|---|---|
| 3 weeks | AG(103) | 48(46.60) | 3.86 | 0.050 |
| NAG(97) | 32(32.99) | |||
| 7 weeks | AG(103) | 95(92.23) | 4.35 | 0.037 |
| NAG(97) | 80(82.47) |